Machine-learning based strategy identifies a robust protein biomarker panel for Alzheimer's disease in cerebrospinal fluid.

Abstract

Authors

• Xiaosen Hou
  Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing, China.
• Yunjie Qiu
  Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing, China.
• Hui Li
  Department of Ophthalmology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
• Yan Yan
  Department of Biomedical Engineering, Wayne State University, Detroit, Michigan, USA.
• Dongxu Zhao
  Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing, China.
• Simei Ji
  Department of Biology, Shenzhen MSU-BIT University, Shenzhen, Guangdong Province, China.
• Junjun Ni
  Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing, China.
• Jun Zhang
  First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
• Kefu Liu
• Hong Qing
  Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing, China. hqing@bit.edu.cn.
• Zhenzhen Quan
  Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, Beijing, China. qzzbit2015@bit.edu.cn.

Keywords

External Resources